1. Home
  2. RAYA vs ANEB Comparison

RAYA vs ANEB Comparison

Compare RAYA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$1.80

Market Cap

4.2M

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$1.07

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
ANEB
Founded
2019
2020
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
46.0M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
RAYA
ANEB
Price
$1.80
$1.07
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
72.6K
Earning Date
04-17-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,101,325.00
N/A
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.78
N/A
52 Week Low
$1.39
$0.90
52 Week High
$736.99
$3.42

Technical Indicators

Market Signals
Indicator
RAYA
ANEB
Relative Strength Index (RSI) 30.08 27.62
Support Level $2.35 $1.01
Resistance Level $2.95 $1.12
Average True Range (ATR) 0.45 0.08
MACD -0.17 0.04
Stochastic Oscillator 13.88 31.82

Price Performance

Historical Comparison
RAYA
ANEB

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: